Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-12-06T06:10:59.007Z Has data issue: false hasContentIssue false

Chapter 11 - Challenges in the Therapy of Psychiatric Disorders in the Elderly

Published online by Cambridge University Press:  01 February 2024

Andrea Fiorillo
Affiliation:
University of Campania “L. Vanvitelli”, Naples
Peter Falkai
Affiliation:
Ludwig-Maximilians-Universität München
Philip Gorwood
Affiliation:
Sainte-Anne Hospital, Paris
Get access

Summary

With the Decade of Healthy Ageing, the WHO has placed a focus on the care of old people. The paper focuses on four key issues that are important for better care of mental health problems in old age. First, behavioral disorders (BPSD) are common in dementia and are a cause of physical, psychological, and social complications. Their management plays a major role. The second article is about the field of neurostimulation, which has been rediscovered in recent years. ECT in particular is very well tolerated by older patients and also by physically ill patients. Other forms of neurostimulation are now being tested. The third article is dedicated to the aim of reducing irrational polypharmacy in old age, which not only contributes to cognitive deterioration but also to increased mortality and fall rates. A relatively new approach is the development of collaborative care structures involving clinical pharmacologists. The last contribution is dedicated to digitalization, which has many advantages, especially in the care of the elderly. The lack of (geriatric) psychiatric care can be partly compensated by the fact that the internet or internet-based help can reach every region (of the world).

Type
Chapter
Information
Mental Health Research and Practice
From Evidence to Experience
, pp. 177 - 196
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cohen-Mansfield, J., Jensen, B. Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: Self-reports of physicians’ practices. J Am Med Dir Assoc. 2008; 9(6): 406413.CrossRefGoogle ScholarPubMed
Cummings, J. L., Mega, M., Gray, K., et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12): 23082314.CrossRefGoogle ScholarPubMed
Higgins, J., Thomas, J. Cochrane handbook for systematic reviews of interventions Version 5.1. 0. London: The Cochrane Collaboration, 2011.Google Scholar
HAS. Prise en charge de la maladie d’Alzheimer et des maladies apparentées: interventions médicamenteuses et non médicamenteuses. Paris: HAS, 2008.Google Scholar
Kales, H. C., Gitlin, L. N., Lyketsos, C. G. Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014; 62(4): 762769.CrossRefGoogle ScholarPubMed
Brodaty, H., Arasaratnam, C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012; 169(9): 946953.CrossRefGoogle ScholarPubMed
Tible, O. P., Riese, F., Savaskan, E., von Gunten, A. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017; 10(8): 297309.CrossRefGoogle ScholarPubMed
Gitlin, L. N., Kales, H. C., Lyketsos, C. G. Nonpharmacologic management of behavioral symptoms in dementia. JAMA. 2012; 308(19): 20202029.CrossRefGoogle ScholarPubMed
National Collaborating Centre for Mental Health (UK). Dementia: A NICE-SCIE guideline on supporting people with dementia and their carers in health and social care. Leicester: British Psychological Society (UK); 2007.Google Scholar
Richter, T., Meyer, G., Möhler, R., Köpke, S. Psychosocial interventions for reducing antipsychotic medication in care home residents. Cochrane Database Syst Rev. 2012; 12(12): CD008634.Google ScholarPubMed
Orrell, M. The new generation of psychosocial interventions for dementia care. Br J Psychiatry. 2012; 201(5): 342343.CrossRefGoogle ScholarPubMed
Bahar-Fuchs, A., Clare, L., Woods, B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev. 2013; 2013(6): CD003260.Google ScholarPubMed
Orgeta, V., Qazi, A., Spector, A. E., Orrell, M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2014; 2014(1): CD009125.Google ScholarPubMed
Tay, K. W., Subramaniam, P., Oei, T. P. Cognitive behavioural therapy can be effective in treating anxiety and depression in persons with dementia: A systematic review. Psychogeriatrics. 2019; 19(3): 264275CrossRefGoogle ScholarPubMed
Charras, K., Zeisel, J., Belmin, J., et al. Effect of personalization of private spaces in special care units on institutionalized elderly with dementia of the Alzheimer type. Non-Pharmacological Therapies in Dementia 2010; 1(2): 121137.Google Scholar
Charras, K., Gzil, F. Judging a book by its cover: Uniforms and quality of life in special care units for people with dementia. Am J Alzheimers Dis Other Demen. 2013; 28(5): 450458.CrossRefGoogle ScholarPubMed
Manera, V., Abrahams, S., Agüera-Ortiz, L., et al. Recommendations for the nonpharmacological treatment of apathy in brain disorders. Am J Geriatr Psychiatry. 2020; 28(4): 410420.CrossRefGoogle ScholarPubMed
Hopkinson, M. D., Reavell, J., Lane, D. A., Mallikarjun, P. Cognitive behavioral therapy for depression, anxiety, and stress in caregivers of dementia patients: A systematic review and meta-analysis. Gerontologist. 2019; 59(4): e343e362.CrossRefGoogle ScholarPubMed
Kwon, O. Y., Ahn, H. S., Kim, H. J., Park, K. W. Effectiveness of cognitive behavioral therapy for caregivers of people with dementia: A systematic review and meta-analysis. J Clin Neurol. 2017; 13(4): 394404.CrossRefGoogle ScholarPubMed
Liu, Z., Sun, Y. Y., Zhong, B. L. Mindfulness-based stress reduction for family carers of people with dementia. Cochrane Database Syst Rev. 2018; 8(8): CD012791.Google ScholarPubMed
Losada, A., Márquez-González, M., Romero-Moreno, R., et al. Cognitive-behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for dementia family caregivers with significant depressive symptoms: Results of a randomized clinical trial. J Consult Clin Psychol. 2015; 83(4): 760772.CrossRefGoogle ScholarPubMed
Cuijpers, P. The effects of family interventions on relatives’ burden: A meta-analysis, J Ment Health, 8(3): 275285CrossRefGoogle Scholar
Cheng, S. T., Au, A., Losada, A., Thompson, L. W., Gallagher-Thompson, D. Psychological interventions for dementia caregivers: What we have achieved, what we have learned. Curr Psychiatry Rep. 2019; 21(7): 59.CrossRefGoogle ScholarPubMed
Miller, M. D. Clinician’s guide to interpersonal psychotherapy in late life: Helping cognitively impaired or depressed elders and their caregivers. Oxford: Oxford University Press; 2009.Google Scholar
American Geriatrics Society. Five things physicians and patients should question. An initiative of the ABIM Foundation. Choosing Wisely. Philadelphia, PA: 2013Google Scholar
Alexopoulos, G. S., Streim, J., Carpenter, D., Docherty, J. P., Expert consensus panel for using antipsychotic drugs in older patients. Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65 Suppl 2: 5104.Google ScholarPubMed
Smith, M., Schultz, S. K., Seydel, L. L., et al. Improving antipsychotic agent use in nursing homes: Development of an algorithm for treating problem behaviors in dementia. J Gerontol Nurs. 2013; 39(5): 2437.CrossRefGoogle ScholarPubMed
Kiosses, D. N., Ravdin, L. D., Gross, J. J., et al. Problem adaptation therapy for older adults with major depression and cognitive impairment: A randomized clinical trial. JAMA Psychiatry. 2015; 72(1): 2230.CrossRefGoogle ScholarPubMed
McDonald, W. M. Neuromodulation treatments for geriatric mood and cognitive disorders. Am J Geriatr Psychiatry. 2016; 24(12):11301141.CrossRefGoogle ScholarPubMed
van Rooij, S. J. H., Riva-Posse, P., McDonald, W. M. The efficacy and safety of neuromodulation treatments in late-life depression. Curr Treat Options Psychiatry. 2020; 7(3): 337–48.Google ScholarPubMed
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet. 2003; 361(9360): 799808.CrossRefGoogle Scholar
Kellner, C. H., Obbels, J., Sienaert, P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand. 2020; 141(4): 304–15.CrossRefGoogle ScholarPubMed
Dols, A., Bouckaert, F., Sienaert, P., et al. Early- and late-onset depression in late life: A prospective study on clinical and structural brain characteristics and response to electroconvulsive therapy. Am J Geriatr Psychiatry. 2017; 25(2): 178189.CrossRefGoogle ScholarPubMed
Birkenhager, T. K., Roos, J., Kamperman, A. M. Improvement after two sessions of electroconvulsive therapy predicts final remission in in-patients with major depression. Acta Psychiatr Scand. 2019; 140(3): 189195.CrossRefGoogle ScholarPubMed
Kellner, C. H., Husain, M. M., Knapp, R. G., et al. Right unilateral ultrabrief pulse ECT in geriatric depression: Phase 1 of the PRIDE study. Am J Psychiatry. 2016; 173(11): 11011109.CrossRefGoogle ScholarPubMed
van Diermen, L., van den Ameele, S., Kamperman, A. M., et al. Prediction of electroconvulsive therapy response and remission in major depression: Meta-analysis. Br J Psychiatry. 2018; 212(2): 7180.CrossRefGoogle ScholarPubMed
van Diermen, L., Poljac, E., Van der Mast, R., et al. Toward targeted ECT: The interdependence of predictors of treatment response in depression further explained. J Clin Psychiatry. 2020;82(1) 20m13287.CrossRefGoogle ScholarPubMed
Kellner, C. H., Greenberg, R. M., Murrough, J. W., et al. ECT in treatment-resistant depression. Am J Psychiatry. 2012; 169(12):1238–44.CrossRefGoogle ScholarPubMed
Kerner, N., Prudic, J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014; 4(1): 3354.CrossRefGoogle ScholarPubMed
Rhebergen, D., Huisman, A., Bouckaert, F., et al. Older age is associated with rapid remission of depression after electroconvulsive therapy: A latent class growth analysis. Am J Geriatr Psychiatry. 2015; 23(3): 274–82.CrossRefGoogle ScholarPubMed
Spaans, H. P., Sienaert, P., Bouckaert, F., et al. Speed of remission in elderly patients with depression: Electroconvulsive therapy v. medication. Br J Psychiatry. 2015; 206(1): 6771.CrossRefGoogle ScholarPubMed
Sienaert, P., Kellner, C. H. Reliable, fast antidepressant treatment: Restating the case for electroconvulsive therapy. Acta Psychiatr Scand. 2019; 140(3): 187188.CrossRefGoogle ScholarPubMed
Obbels, J., Verwijk, E., Vansteelandt, K., et al. Long-term neurocognitive functioning after electroconvulsive therapy in patients with late-life depression. Acta Psychiatr Scand. 2018; 138(3): 223231.CrossRefGoogle ScholarPubMed
Obbels, J., Vansteelandt, K., Bouckaert, F., et al. Neurocognitive functioning after electroconvulsive therapy in late-life depression: A 4-year prospective study. Acta Psychiatr Scand. 2021; 143(2): 141150.CrossRefGoogle ScholarPubMed
Semkovska, M., McLoughlin, D. M. Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biol Psychiatry. 2010; 68(6): 568577.CrossRefGoogle ScholarPubMed
Jurek, L., Dorey, J. M., Nourredine, M., Galvao, F., Brunelin, J. Impact of vascular risk factors on clinical outcome in elderly patients with depression receiving electroconvulsive therapy. J Affect Disord. 2021; 279:308315.CrossRefGoogle ScholarPubMed
Spaans, H. P., Kok, R. M., Bouckaert, F., et al. Vascular risk factors in older patients with depression: Outcome of electroconvulsive therapy versus medication. Int J Geriatr Psychiatry. 2018; 33(2): 371378.CrossRefGoogle ScholarPubMed
Bouckaert, F., Emsell, L., Vansteelandt, K., et al. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes. J Affect Disord. 2019; 251: 114120.CrossRefGoogle ScholarPubMed
Elias, A., Phutane, V. H., Clarke, S., Prudic, J. Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses. Aust N Z J Psychiatry. 2018; 52(5): 415424.CrossRefGoogle ScholarPubMed
Sahlem, G. L., McCall, W. V., Short, E. B., et al. A two-site, open-label, non-randomized trial comparing focal electrically-administered seizure therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT). Brain Stimul. 2020; 13(5): 14161425.CrossRefGoogle ScholarPubMed
Mutz, J., Vipulananthan, V., Carter, B., et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: Systematic review and network meta-analysis. BMJ. 2019; 364: l1079.CrossRefGoogle ScholarPubMed
Iriarte, I. G., George, M.S. Transcranial magnetic stimulation (TMS) in the elderly. Curr Psychiatry Rep. 2018; 20(1): 6.CrossRefGoogle ScholarPubMed
Jorge, R. E., Moser, D. J., Acion, L., Robinson, R. G. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008; 65(3): 268276.CrossRefGoogle ScholarPubMed
Sabesan, P., Lankappa, S., Khalifa, N., et al. Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World J Psychiatry. 2015; 5(2): 170181.CrossRefGoogle ScholarPubMed
Kaster, T. S., Daskalakis, Z. J., Noda, Y., et al. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: A prospective randomized controlled trial. Neuropsychopharmacology. 2018; 43(11): 22312238.CrossRefGoogle ScholarPubMed
Trevizol, A. P., Goldberger, K. W., Mulsant, B. H., et al. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression. Int J Geriatr Psychiatry. 2019; 34(6): 822827.CrossRefGoogle ScholarPubMed
Ren, J., Li, H., Palaniyappan, L., et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 51: 181189.CrossRefGoogle ScholarPubMed
Lisanby, S. H., Luber, B., Schlaepfer, T. E., Sackeim, H. A. Safety and feasibility of magnetic seizure therapy (MST) in major depression: Randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology. 2003; 28(10): 18521865.CrossRefGoogle ScholarPubMed
Kayser, S., Bewernick, B. H., Wagner, S., Schlaepfer, T. E. Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment-resistant depression. Depress Anxiety. 2020; 37(2): 125133.CrossRefGoogle Scholar
Brunoni, A. R., Moffa, A. H., Fregni, F., et al. Transcranial direct current stimulation for acute major depressive episodes: Meta-analysis of individual patient data. Br J Psychiatry. 2016; 208(6): 522531.CrossRefGoogle ScholarPubMed
Loo, C. K., Alonzo, A., Martin, D., et al. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012; 200(1): 5259.CrossRefGoogle ScholarPubMed
Zanardi, R., Poletti, S., Prestifilippo, D., et al. Transcranial direct current stimulation: A novel approach in the treatment of vascular depression. Brain Stimul. 2020; 13(6): 15591565.CrossRefGoogle ScholarPubMed
Martin, D. M., Moffa, A., Nikolin, S., et al. Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: An individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev. 2018; 90: 137145.CrossRefGoogle ScholarPubMed
Alexopoulos, G. S., Katz, I. R., Bruce, M. L., et al. Remission in depressed geriatric primary care patients: A report from the PROSPECT study. Am J Psychiatry. 2005; 162(4): 718724.CrossRefGoogle ScholarPubMed
Kok, R. M., Nolen, W. A., Heeren, T. J. Outcome of late-life depression after 3 years of sequential treatment. Acta Psychiatr Scand. 2009; 119(4): 274281.CrossRefGoogle ScholarPubMed
Unützer, J., Katon, W., Callahan, C. M., et al. Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA. 2002; 288(22): 28362845.CrossRefGoogle ScholarPubMed
Grover, S., Dalla, E., Mehra, A., et al. Physical comorbidity and its impact on symptom profile of depression among elderly patients attending psychiatry services of a tertiary care hospital. Indian J Psychol Med 2017; 39(4): 450456.CrossRefGoogle ScholarPubMed
Stuhec, M., Stoppe, G. Psychopharmacotherapy in aged patients. In Riederer, P., Laux, G., Nagatsu, T., Le W., Riederer, C. (eds.) NeuroPsychopharmacotherapy. Cham: Springer, 2020.Google Scholar
Tham, A., Jonsson, U., Andersson, G., et al. Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder: A systematic review and a meta-analysis. J Affect Disord 2016; 205: 112.CrossRefGoogle ScholarPubMed
Maher, R. L., Hanlon, J., Hajjar, E. R. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 5765.CrossRefGoogle ScholarPubMed
Leelakanok, N., Holcombe, A. L., Lund, B. C., et al. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc 2003; 57(6): 729738.e10.CrossRefGoogle Scholar
Park, H. Y., Park, J. W., Song, H. J., et al. The association between polypharmacy and dementia: A nested case-control study based on a 12-year longitudinal cohort database in South Korea. PLoS One 2017; 12(1):e0169463.CrossRefGoogle ScholarPubMed
Janssens, B., Petrovic, M., Jacquet, W. Medication use and its potential impact on the oral health status of LTCF residents in Flanders (Belgium). J Am Med Dir Assoc 2017; 18(9): 809.e1–809.e8CrossRefGoogle Scholar
Ballard, C., Hanney, M. L., Theodoulou, M., et al. The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8(2): 151157.CrossRefGoogle ScholarPubMed
Taipale, H., Tanskanen, A., Mehtälä, J., et al. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 2020; 19(1): 6168.CrossRefGoogle Scholar
Howard, R., Cort, E., Bradley, R., et al. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): A randomised, controlled, double-blind trial. Lancet Psychiatry 2018; 5: 553563.CrossRefGoogle Scholar
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019; 67(4): 674694.CrossRefGoogle Scholar
Holt, S., Schimedel, S., Thürmann, A. P. Potentially inappropriate medications in the elderly: The PRISCUS list. Dtsch Arztebl Int 2010; 107: 543551.Google ScholarPubMed
Gallagher, P., Ryan, C., Byrne, S., et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46(2): 7283CrossRefGoogle ScholarPubMed
O’Mahony, D., O’Sullivan, D., Byrne, S., et al. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015; 44(2): 213218.CrossRefGoogle ScholarPubMed
Mann, E., Haastert, B., Böhmdorfer, B., et al. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: Secondary analysis of a cross-sectional study. Wien Klin Wochenschr 2013; 125(7–8): 180188.CrossRefGoogle ScholarPubMed
Counter, D., Millar, J. W. T., McLay, J. S. Hospital readmissions, mortality and potentially inappropriate prescribing: A retrospective study of older adults discharged from hospital. Br J Clin Pharmacol 2018; 84(8): 17571763.CrossRefGoogle ScholarPubMed
Pasina, L., Colzani, L., Cortesi, L., et al. Relation between delirium and anticholinergic drug burden in a cohort of hospitalized older patients: An observational study. Drugs Aging 2019; 36(1): 8591.CrossRefGoogle Scholar
ABC Calculator. www.acbcalc.com/ (last accessed February 15, 2021).Google Scholar
Campbell, N., Boustani, M., Lane, K, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010; 75: 152159.CrossRefGoogle Scholar
Fox, C., Richardson, K., Maidment, I., et al. Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. Am Geriatr Soc 2011; 59(8): 14771483.CrossRefGoogle ScholarPubMed
Štuhec, M., Potočin, I., Stepan, D., et al. Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers. Int J Clin Pharm 2019; 41(4): 932938.CrossRefGoogle ScholarPubMed
Štuhec, M., Gorenc, K., Zelko, E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: A cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res 2019; 19(1): 118.CrossRefGoogle ScholarPubMed
Sultana, J., Giorgianni, F., Rea, F., et al. All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: A multi-center retrospective cohort study in Italy. Expert Opin Drug Metab Toxicol 2019; 15(2): 179188.CrossRefGoogle Scholar
Zheng, W. Y., Richardson, L. C., Li, L., et al. Drug-drug interactions and their harmful effects in hospitalised patients: A systematic review and meta-analysis. Eur J Clin Pharmacol 2018; 74(1): 1527.CrossRefGoogle ScholarPubMed
Stuhec, M., Bratović, N., Mrhar, A. Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep 2019; 9: 16856.CrossRefGoogle ScholarPubMed
Stuhec, M., Tement, V. Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital. Sci Rep. 2021;11(1): 13641.CrossRefGoogle ScholarPubMed
Leng, M., Liu, P., Zhang, P., et al. Pet robot intervention for people with dementia: A systematic review and meta-analysis of randomized controlled trials. Psychiatry Res. 2019; 271: 516–25.CrossRefGoogle ScholarPubMed
Lu, L. C., Lan, S. H., Hsieh, Y. P., et al. Effectiveness of companion robot care for dementia: A systematic review and meta-analysis. Innov Aging. 2021; 5(2): igab013.CrossRefGoogle ScholarPubMed
Martinez-Alcala, C. I., Pliego-Pastrana, P., Rosales-Lagarde, A., Lopez-Noguerola, J. S., Molina-Trinidad, E. M. Information and communication technologies in the care of the elderly: Systematic review of applications aimed at patients with sementia and caregivers. JMIR Rehabil Assist Technol. 2016; 3: e6.CrossRefGoogle Scholar
van Straten, A., van der Zweerde, T., Kleiboer, A., et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018; 38: 316.CrossRefGoogle ScholarPubMed
Horsch, C. H., Lancee, J., Griffioen-Both, F., et al. Mobile phone-delivered cognitive behavioral therapy for insomnia: A randomized waitlist controlled trial. J Med Internet Res. 2017; 19(4): e70.CrossRefGoogle ScholarPubMed
Karyotaki, E., Efthimiou, O., Miguel, C., et al. Internet-based cognitive behavioral therapy for depression: A systematic review and individual patient data Network meta-analysis. JAMA Psychiatry. 2021;78: 361371.CrossRefGoogle ScholarPubMed
Manoharan, A., McMartin, K., Young, C., et al. Internet-delivered cognitive behavioural therapy for major depression and anxiety disorders: A health technology assessment. Ont Health Technol Assess Ser. 2019; 19: 1199.Google Scholar
Xiang, X., Wu, S., Zuverink, A., Tomasino, K. N., An, R., et al. Internet-delivered cognitive behavioral therapies for late-life depressive symptoms: A systematic review and meta-analysis. Aging Ment Health. 2020; 24: 11961206.CrossRefGoogle ScholarPubMed
Reins, J. A., Buntrock, C., Zimmermann, J., et al. Efficacy and moderators of internet-based interventions in adults with subthreshold depression: An individual participant data meta-analysis of randomized controlled trials. Psychother Psychosom. 2021; 90: 94106.CrossRefGoogle ScholarPubMed
Simon, N., Robertson, L., Lewis, C., et al. Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2021; 5: CD011710.Google ScholarPubMed
Wagner, B., Maercker, A. A 1.5 year follow-up of an internet-based intervention for complicated grief. J Traumat Stress. 2007; 20: 625629.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×